サクサク読めて、アプリ限定の機能も多数！
タグをすべて表示
ランキング
リリース、障害情報などのサービスのお知らせ
最新の人気エントリーの配信
処理を実行中です
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
1
Blue chip venture groups arm gene therapy upstart with $41M launch round
Biotech startup Avitide attracts venture funding from familiar VC crowd
New $80M venture fund to back startups entering 'valley of death'
GlaxoSmithKline commits venture cash to new $250M biotech startup fund
In biotech trifecta, startup lassos $31M, a CEO and a lead drug from Pfizer
Gates Foundation backs $13M venture add for flu drug developer
UPDATED: Ex-Pfizer crew snags $27M financing for U.K. drugs startup
http://www.fiercebiotech.com/story/ex-pfizer-crew-snags-27m-financing-uk-drugs-startup/2012-11-04
Two Texas biotech outfits lasso venture deals totaling $81M
Startup biotech hauls in $23M A round for antiviral work
Elcelyx busts out of stealth mode as it hunts obesity, diabetes pacts
Pfizer taps biotech startup to tailor R&D of lupus, autoimmune drugs
Biotech startup Atterocor grabs $16M A round for cancer compound
The Top 15 Biotech Venture Investments in H1 2012
Life Sciences Venture Capital Funding Falls 22% in Q1 2012, According to the MoneyTree Report
VCs pump more cash into late-stage efforts as startup rounds shrivel
Frazier preps venture fund to back biotechs built for sale
UPDATED: Fueled by Sanofi, Warp Drive Bio takes off with $125M deal
Canaan Partners adds $200M in venture funds for life sciences